Thus, Aβ42 association with the Igf2 DMR on the Igf2 promoter provides a nonconical mechanism for reduced IGF2 levels in 5xFAD mice and AD patients, independent of H19 ICR DNA methylation. This evidence concerns the gene IGF2 and Alzheimer disease.